Sandoz Set To Become Public Company In 2023 As Novartis Confirms Spin-Off

No Formal Offers Received For Sandoz To Date But Novartis Would Have To Consider

 
• By Dean Rudge
  
Spinning-Tops
Novartis received no formal or binding offers • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business